Showing results (1151-1160 of 1,221) with videos related to
Sort By:
Pageof 123
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory NeuroblastomaSteven G DuBois, Susan Groshen, Julie R Park, et al.Nature Communications|May 5, 2023
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastomaEsther R Berko, Gabriela M Witek, Smita Matkar, et al.Nature Medicine|July 13, 2021
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A Vitanza, Adam J Johnson, Ashley L Wilson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.Pediatric Blood & Cancer|June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology CommitteeRie Suganuma, Larry L Wang, Hideki Sano, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2024
Financial burden following adult liver transplantation is common and associated with adverse recipient outcomesNneka N Ufere, Marina Serper, Alyson Kaplan, et al.Cancer|February 11, 2025
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastomaSteven G DuBois, Chitose Ogawa, Lucas Moreno, et al.BMC Public Health|July 15, 2022
Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]Brett M Goshe, Autumn W Rasmussen, Lynne I Wagner, et al.Journal of Hematology Oncology Pharmacy|September 6, 2024
Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy ActivitiesNicholas A Vitanza, Michelle Choe, Christopher Brown, et al.Pediatric Blood & Cancer|July 29, 2024
A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter studyAndres F Espinoza, Rochelle Bagatell, Kieran McHugh, et al.Pageof 123